Nirsevimab Respiratory Syncytial Virus monoclonal antibody

BIOLOGICAL2 trials

Sponsors

Sanofi

Conditions

RSV Immunization

Unknown Phase

RSV Immunisation Status in Queensland (Australia)

RecruitingNCT07615192

SanofiRSV Immunization

Start: 2026-05-29End: 2026-09-30Target: 1200Updated: 2026-09-18

An Observational Study to Assess Nirsevimab Immunization Rates in Eligible Infants During Their First RSV Season in the Czechia

CompletedNCT07634692

SanofiRSV Immunization

Start: 2026-06-15End: 2026-06-26Updated: 2026-08-10